Valuation: IRADIMED CORPORATION

Market Cap 1.12B 962M 900M 824M 1.55B 107B 1.57B 10.64B 4.15B 53.99B 4.22B 4.13B 179B P/E 2026 *
45.8x
P/E 2027 * 39.6x
Enterprise Value 1.12B 962M 900M 824M 1.55B 107B 1.57B 10.64B 4.15B 53.99B 4.22B 4.13B 179B EV / Sales 2026 *
12.3x
EV / Sales 2027 * 11.1x
Free-Float
64.81%
Yield 2026 *
-
Yield 2027 * -
1 day+1.35%
1 week+1.04%
Current month-3.31%
1 month-6.62%
3 months-4.61%
6 months-15.17%
Current year-9.69%
1 week 85.57
Extreme 85.57
89.03
1 month 85
Extreme 85
97.74
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
30/3/26 Sell

Chief Executive Officer

7,500 0.0590%
13/2/26 Sell

Director

1,000 0.0079%
26/1/26 Sell

Chief Executive Officer

5,000 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
+1.35%+1.04%+20.91%+85.85% 1.12B
-3.63%-2.21%-21.70%-2.75% 12.89B
+2.01%+3.74%+26.51%+17.89% 4.7B
-0.05%0.00%-40.05%-51.01% 1.31B
-3.38%-2.02%-38.23%-36.86% 1.17B
-7.45%-11.96%-40.27% - 1.06B
-0.58%-6.74%+48.32%+131.91% 557M
+1.86%-6.81%+50.50% - 301M
-1.91%-1.45%-63.70%+311.94% 257M
+0.38%-10.70%+29.93%-11.00% 167M
Average -1.14%-3.82%-2.78%+55.75% 2.35B
Weighted average by Cap. -2.04%-1.58%-10.22%+8.45%

Financials

2026 *2027 *
Net sales 91.2M 78.12M 73.1M 66.91M 126M 8.73B 127M 864M 337M 4.38B 342M 335M 14.5B 101M 86.52M 80.95M 74.1M 139M 9.66B 141M 956M 373M 4.85B 379M 371M 16.06B
Net income 24.65M 21.12M 19.76M 18.09M 33.94M 2.36B 34.39M 233M 91.03M 1.18B 92.56M 90.54M 3.92B 28.45M 24.37M 22.8M 20.87M 39.17M 2.72B 39.69M 269M 105M 1.37B 107M 105M 4.52B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
21/08/26 US$87.85 +1.35% 76,178
20/08/26 US$86.68 -0.82% 80,014
19/08/26 US$87.40 -0.17% 100,863
18/08/26 US$87.55 -0.53% 66,903
17/08/26 US$88.02 +1.23% 106,373
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
87.85USD
Average target price
118.00USD
Spread / Average Target
+34.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock